Sam Pyo Hong

484 total citations
13 papers, 388 citations indexed

About

Sam Pyo Hong is a scholar working on Oncology, Oral Surgery and Molecular Biology. According to data from OpenAlex, Sam Pyo Hong has authored 13 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Oral Surgery and 2 papers in Molecular Biology. Recurrent topics in Sam Pyo Hong's work include Oral and Maxillofacial Pathology (4 papers), HER2/EGFR in Cancer Research (2 papers) and Oral and Craniofacial Lesions (2 papers). Sam Pyo Hong is often cited by papers focused on Oral and Maxillofacial Pathology (4 papers), HER2/EGFR in Cancer Research (2 papers) and Oral and Craniofacial Lesions (2 papers). Sam Pyo Hong collaborates with scholars based in South Korea, United States and Singapore. Sam Pyo Hong's co-authors include Kenton S. Hartman, Gary L. Ellis, Sung‐Min Kang, Giuseppe Curigliano, William J. Gradishar, Shakeela Bahadur, Fátima Cardoso, Mark D. Pegram, Seong‐Doo Hong and Seock‐Ah Im and has published in prestigious journals such as Journal of Clinical Oncology, Oral Oncology and Journal of Oral Pathology and Medicine.

In The Last Decade

Sam Pyo Hong

13 papers receiving 369 citations

Peers

Countries citing papers authored by Sam Pyo Hong

Since Specialization

Citations

This map shows the geographic impact of Sam Pyo Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Pyo Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Pyo Hong more than expected).

Fields of papers citing papers by Sam Pyo Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Pyo Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Pyo Hong. The network helps show where Sam Pyo Hong may publish in the future.

Co-authorship network of co-authors of Sam Pyo Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Pyo Hong. A scholar is included among the top collaborators of Sam Pyo Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Pyo Hong. Sam Pyo Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) + Ctx versus trastuzumab (T) + Ctx in patients (pts) with pretreated HER2+ metastatic (met) breast cancer (MBC). 2020 ·Journal of Clinical Oncology ·(unknown), Seock‐Ah Im, Fátima Cardoso, Javier Cortés, Giuseppe Curigliano, William J. Gradishar, Mark D. Pegram, (unknown), Christelle Lévy, Michelino De Laurentiis, Jean-Marc Ferrero, Shakeela Bahadur, Sung‐Bae Kim, Katarína Petráková, David Riseberg, Denise A. Yardley, (unknown), Sam Pyo Hong, Edwin P. Rock, Hope S. Rugo	5
2	SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx). 2019 ·Journal of Clinical Oncology ·Hope S. Rugo, Seock‐Ah Im, (unknown), Santiago Escrivá-de-Romaní, Michelino De Laurentiis, Javier Cortés, Shakeela Bahadur, Barbara Haley, (unknown), David Riseberg, Antonino Musolino, Fátima Cardoso, Giuseppe Curigliano, Peter A. Kaufman, Mark D. Pegram, (unknown), Sam Pyo Hong, Edwin P. Rock, William J. Gradishar	62
3	Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T). 2018 ·Journal of Clinical Oncology ·Daniel V.T. Catenacci, Haeseong Park, Hope E. Uronis, Yoon‐Koo Kang, Jill Lacy, Peter C. Enzinger, Se Hoon Park, Keun Wook Lee, Matthew Chau Hsien Ng, Philip J. Gold, Jennifer Yen, Aleksandra Franovic, Ronan J. Kelly, (unknown), Daner Li, John Muth, Jan Baughman, Sam Pyo Hong, Jan Davidson‐Moncada, Yung‐Jue Bang	12
4	Phase 1b/2 study of margetuximab (M) plus pembrolizumab (P) in advanced HER2+ gastroesophageal junction (GEJ) or gastric (G) adenocarcinoma (GEA). 2018 ·Journal of Clinical Oncology ·Daniel V.T. Catenacci, Haeseong Park, A. Craig Lockhart, Philip J. Gold, Peter C. Enzinger, Jeffrey L. Nordstrom, Sam Pyo Hong, Howard S. Höchster, Ronan J. Kelly, Hope E. Uronis, Johanna C. Bendell, Sang Cheul Oh, Se Hoon Park, Yeul Hong Kim, Yoon‐Koo Kang, Keun‐Wook Lee, Matthew Chau Hsien Ng, Jon M. Wigginton, Jan Davidson‐Moncada, Yung‐Jue Bang	14
5	Prognostic significance of nestin in primary malignant melanoma of the oral cavity 2016 ·Melanoma Research ·(unknown), Chong Hyun Won, Woo Jin Lee, (unknown), (unknown), Seong‐Doo Hong, Sam Pyo Hong, (unknown)	10
6	Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer 2016 ·Oral Oncology ·(unknown), (unknown), Seong‐Doo Hong, Sam Pyo Hong, Jae Il Lee	6
7	Osteochondroma of the Zygoma: Report of Case and Review of Literature 2015 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·(unknown), (unknown), (unknown), (unknown), Sam Pyo Hong, (unknown)	1
8	Cholesterol Granuloma in the Mandible 2007 ·Jihong Kim, Seong‐Doo Hong, Jae Il Lee, Sam Pyo Hong	1
9	Ameloblastic Carcinoma of the Jaw 2007 ·(unknown), Seong‐Doo Hong, Jae Il Lee, Sam Pyo Hong	6
10	Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki‐67 and prognosis 2003 ·Journal of Oral Pathology and Medicine ·(unknown), Sung‐Min Kang, (unknown), (unknown), (unknown), (unknown), Sam Pyo Hong, (unknown)	73
11	High-Throughput Analysis in Catalysis Research Using Novel Approaches to Transmission Infrared Spectroscopy 2003 ·Journal of Combinatorial Chemistry ·(unknown), David R. Neithamer, (unknown), (unknown), (unknown), Sam Pyo Hong, (unknown), Kenneth R. Beyerlein	14
12	Calcifying odontogenic cyst 1991 ·Oral Surgery Oral Medicine Oral Pathology ·Sam Pyo Hong, Gary L. Ellis, Kenton S. Hartman	177
13	Melanotic neuroectodermal tumor of infancy 1986 ·Journal of Korean Medical Science ·(unknown), Sam Pyo Hong, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact